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Introduction
Before spontaneous labor, induction of labor may be indi-
cated if the advantages of pregnancy termination outweigh 
the advantages of its continuation [1]. The rate of labor 
induction in the United States has increased by 2.5 times 
from 9.5% in 1990 to 25.7% in 2017 [2]. Some indications 
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for labor induction include severe pre-eclampsia, post-term 
pregnancy, and premature rupture of membranes [3]. 
Cervical status and its ripening are important factors for 
successful induction of labor. There are different pharmaco-
logical and mechanical methods for cervical ripening. The 
best cervical ripening method is selected based on its effec-
tiveness and safety and also patient’s medical and obstetric 
history and clinical characteristics [4]. Administration of miso-
prostol, or prostaglandin E1, is one of the pharmacological 
methods for cervical ripening. It is used either vaginally or 
orally. It affects the amount of cervical collagen production, 
increases the degradation of the collagen matrix in the cer-
vix, and thereby, softens and ripens the cervix. Moreover, 
it induces uterine contractions. However, misoprostol, par-
ticularly at doses of more than 50 µg, increases the need for 
cesarean sections and the risks of hyperstimulation, uterine 
ruptures, neonatal intensive care unit admissions, and meco-
nium staining [5]. Because of the serious adverse effects of 
pharmacological methods for cervical ripening, mechanical 
methods have recently received great attention and exten-
sive research has been done on their effectiveness [6]. These 
methods include extra-amniotic saline infusions (EASI) via 
transcervical catheters, hygroscopic dilators such as lami-
naria, and membrane stripping. Transcervical catheters are 
used either with or without saline infusions. Laminaria is a 
synthetic type of sea algae which induces cervical dilation by 
absorbing water from the cervix and gradually increasing in 
thickness [3]. 
To date, different studies have been conducted on the ef-
fects and safety of pharmacological and mechanical methods 
for cervical ripening. Yet, controversies still exist over the 
best cervical ripening method [7]. A study reported that the 
time interval from labor induction to the labor active phase 
in the EASI group was shorter than that in the laminaria 
group, and there were no significant differences in complica-
tions between these 2 methods [8]. One study indicated that 
misoprostol was more effective than laminaria in increasing 
the Bishop scores and shortening labor durations, though 
cesarean section rates in the misoprostol group were greater 
[9]. However, another study found that although this interval 
was shorter in the laminaria group than in the misoprostol 
group, the difference was not statistically significant. More-
over, the rates of cesarean sections and uterine hyperstimula-
tion were greater in the misoprostol group [10]. A compara-
tive study into the effects of EASI and misoprostol found 
that induction-labor time intervals and Bishop score changes 
were significantly lower in the misoprostol group than in the 
EASI group, while uterine hyperactivity and ruptures were 
significantly more prevalent in the misoprostol group. That 
study concluded that 100 µg misoprostol suppositories were 
more effective than EASI catheters in cervical ripening and 
labor induction, but recommended further studies to deter-
mine safe doses of misoprostol [11]. A study concluded that 
when pregnancy termination was needed and the cervix was 
not ripe, vaginal misoprostol was more effective than EASI in 
shortening labor durations and reducing the need for cesar-
ean sections [7]. The results of another study illustrated that 
there were no significant differences between the misopro-
stol and EASI groups regarding neonatal Apgar scores, me-
conium staining rates, cesarean section rates, and the time 
intervals between labor induction and labor active phases; 
however, the time interval between labor induction and de-
livery in the misoprostol group was significantly shorter than 
that in the EASI group [12]. However, a meta-analysis study 
reported no significant differences between misoprostol and 
EASI methods regarding cesarean section rates and the time 
intervals from labor induction to active labor phases and de-
livery [13].
These contradictory results of previous studies highlight the 
necessity of additional studies on the effects of pharmaco-
logical and mechanical cervical ripening methods. Moreover, 
none of the previous studies compared the effects of these 
3 methods for cervical ripening. Therefore, the present study 
was conducted to compare the effects of vaginal misopros-
tol, laminaria, and EASI on cervical ripening and labor induc-
tion.
Materials and methods
1. Participants
This 3-group randomized controlled trial was conducted on 
195 pregnant women who required cervical ripening and 
labor inductions. Participants were recruited in 2017–2018 
from Shahid Beheshti and Shabihkhani hospitals, Kashan, 
Iran. Inclusion criteria were: a live fetus with cephalic pre-
sentation, a normal nonstress test, a gestational age of 
37 weeks or more, fetal weight less than 4 kilograms, a 
Bishop score less than 5, no labor pains, and no contraindi-
cations for vaginal delivery. Participants were excluded if they 
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developed fetal distress, thick meconium-stained amniotic 
fluid, fever, chorioamnionitis, or vaginal bleeding before in-
tervention.
 
2. Sample size
Sample size was calculated using the results of a previous 
study [8] which reported that the time intervals between la-
bor induction and delivery in the Foley catheter and laminaria 
groups were 10.3±4.35 and 12.5±4.9 hours, respectively. 
With a confidence level of 95% and a power of 80%, the 
sample size was estimated to be 65 per group. Using an 
online random number generator and through permuted 
block randomization with a block size of 6, all 195 eligible 
pregnant women were randomly allocated to groups A 
(misoprostol), B (laminaria), or C (EASI). Sequentially num-
bered opaque sealed envelopes were used for allocation 
concealment. The generated allocation sequence was writ-
ten on cards and the cards were put into envelopes. For each 
new participant, 1 envelope was opened, and her group was 
determined based on the label on the card.
3. Intervention
Participants in the misoprostol group received a single 25-µg 
vaginal misoprostol suppository (Cytotex, Searle, England). 
The suppository was placed in the posterior fornix of the va-
gina. In the laminaria group, the cervix was initially washed 
with povidone-iodine, and laminaria were placed inside us-
ing ring forceps. In the EASI group, a Foley catheter (size 22) 
was placed under sterile conditions in the uterus through the 
cervix and its balloon was filled with 40 mL of distilled water 
so that the balloon was located behind the internal orifice 
of the uterus. The other end of the catheter was connected 
to a 500 mL saline solution bottle, and the infusion rate 
was set at 40 mL per hour. The catheter was in place until 
spontaneously expelled from the uterus. All women in the 3 
groups underwent vaginal examinations every 2 hours, and 
their Bishop scores were calculated. If any participant did not 
spontaneously enter the active phase of labor after 6 hours 
(i.e., did not have regular uterine contractions and progres-
sive cervical changes), oxytocin was used for labor induc-
tion according to the hospital protocol, and the patient was 
Fig. 1. Consort diagram. EASI, extra-amniotic saline infusion.
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monitored until delivery. The 3 groups were also assessed 
for complications, including dilatation arrest, uterine hyper-
tonicity, tachysystole (i.e., at least 5 uterine contractions per 
10 minutes), placental abruption, meconium staining, and 
fetal distress. 
A checklist was used to document study outcomes and in-
cluded maternal age, gestational age, body mass index (BMI), 
baseline and 6-hour cervical dilation, Bishop scores, the time 
intervals from labor induction to labor active phase and deliv-
ery, route of delivery, and ripening method complications.
4. Statistical data analysis
Data analysis was performed using a SPSS program (version 
16.0; SPSS Inc., Chicago, IL, USA). Within- and between-
group comparisons regarding numerical variables were ana-
lyzed using the paired sample t-test and 1-way analysis of 
variance with post hoc analysis, respectively. Between-group 
comparisons regarding categorical variables were analyzed 
using the χ2 test. The level of significance was set at less than 
0.05. 
Results
In total, 210 women were assessed for eligibility and 195 
eligible women were studied in 3 groups (Fig. 1). Findings re-
vealed no significant differences among the groups regarding 
participants’ demographic and reproductive characteristics 
and causes of labor induction (Table 1).
There was no significant among-group difference with re-
gard to the pretest mean of Bishop scores (P=0.066). Howev-
er, 6 hours after the intervention, the mean post-test Bishop 
scores among groups differed significantly from each other 
(P<0.001). The results of the Tukey’s post hoc test indicated 
that the mean of the posttest Bishop scores in the laminaria 
group was significantly less than those in the misoprostol 
and the EASI groups (P<0.001), while there were no signifi-
cant differences between the misoprostol and EASI groups 
(P=0.13). Moreover, within group comparisons revealed that 
the means of the posttest Bishop scores in all 3 groups were 
significantly greater than their corresponding pretest values 
(P<0.001; Table 2). 
There was no statistically significant difference among the 
groups regarding the pretest mean values of cervical dila-
tion (P=0.441), while the among group difference regarding 
the posttest mean value of cervical dilation was statistically 
significant (P<0.001). The Tukey’s post hoc test showed that 
the posttest mean value of cervical dilation in the EASI group 
was significantly greater than those in the other 2 groups, 
and the post-test mean value of cervical dilation in the 
misoprostol group was significantly greater than that in the 
laminaria group (P<0.001). Within group comparisons also 
Table 1. Comparison of demographic and reproductive characteristics among the 3 groups
Variables
Groups
P-value
Misoprostol Laminaria EASI
Maternal age (range 15–40 yr) 28.32±4.98 27.29±6.05 28.20±5.56 0.513
Gestational age (range 37–41 wk) 38.94±1.17 38.52±2.12 39.06±1.14 0.118
BMI 27.57±5.0 26.48±6.37 26.74±4.75 0.490
Parity
Nullipara 34 (52.3) 32 (49.2) 37 (56.9) 0.676
Multipara 31 (47.7) 33 (50.8) 28 (43.1)
Cause of induction
PIH 25 (38.4) 22 (33.8) 20 (30.7) 0.860
Postdate 30 (46.2) 32 (49.2) 31 (47.7) -
Oligohydramnios 5 (7.7) 4 (6.2) 4 (6.2) -
Maternal diseases (diabetes, chronic 
hypertension…)
5 (7.7) 7 (10.8) 10 (15.4) -
Data are shown as mean±standard deviation or number (%).
BMI, body mass index; PIH, pregnancy-induced hypertension; EASI, extra-amniotic saline infusion.
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revealed that the posttest mean values of cervical dilation in 
all groups were significantly greater than their corresponding 
pretest values (P<0.001; Table 2).
The groups also differed significantly from each other re-
garding the time intervals from labor induction to labor active 
phase and delivery (P<0.001). The results of the Tukey’s post 
hoc test revealed that the time interval in the EASI group was 
significantly shorter than that in the other 2 groups (P<0.01). 
Moreover, the time interval in the misoprostol group was 
significantly shorter than that in the laminaria group (P<0.01; 
Table 2). 
Among group differences regarding the lengths of hospi-
tal stays were statistically significant (P<0.001). The Tukey’s 
post hoc test showed that the length of hospital stay in the 
EASI group was significantly shorter than that in the other 
2 groups; it was significantly shorter in the laminaria group 
than in the misoprostol group (P<0.05). 
The groups also significantly differed from each other re-
garding the routes of delivery (P=0.026). Pairwise compari-
sons indicated that the rate of vaginal delivery in the EASI 
group (81.5%) was significantly higher than that in the miso-
prostol group (60%) (P=0.007). However, the differences 
between the misoprostol and laminaria groups and between 
the EASI and laminaria groups regarding the rates of vaginal 
deliveries were not significant (P>0.05; Table 2).
There were significant differences among the groups re-
garding meconium staining, placental abruption, and fetal 
distress. The highest prevalence rates of meconium staining 
(16.9%), placental abruption (15.4%), and fetal distress 
(21.5%) were observed in the misoprostol group (Table 3). 
After adjusting for possible confounders, the analysis of co-
variance model showed that maternal age, gestational age, 
Table 2. Among-group comparisons according to ripening outcomes
Variables
Groups
P-value
Misoprostol Laminaria EASI
Bishop score Baseline 2.42±0.61 2.42±0.66 2.65±0.67 0.066
6 hours later 6.25±1.59 5.09±0.91 6.74±1.71 <0.001
P-value <0.001 <0.001 <0.001
Dilatation Baseline 1.12±0.33 1.14±0.35 1.20±0.40 0.441
6 hours later 2.66±0.83 2.25±0.56 3.17±0.72 <0.001
P-value <0.001 <0.001 <0.001
Interval between intervention to active phase (hr) 8.03±2.57 9.57±1.92 5.74±2.63 <0.001
Interval between intervention to delivery (hr) 11.40±3.51 13.12±2.81 9.25±3.20 <0.001
Length of stay in hospital (day) 2.26±1.06 1.88±0.82 1.49±0.77 <0.001
Type of delivery Vaginal 39 (60) 46 (70.8) 53 (81.5) 0.026
Cesarean 26 (40) 19 (29.2) 12 (18.5)
Data are shown as mean±standard deviation or number (%).
EASI, extra-amniotic saline infusion.
Table 3. Among-group comparisons according to ripening complications
Complications
Groups
P-value
Misoprostol Laminaria EASI
Dilatation arrest 8 (12.3) 7 (10.8) 6 (9.2) 0.852
Meconium staining 11 (16.9) 4 (6.2) 2 (3.1) 0.013
Chorioamnionitis 2 (3.1) 1 (1.5) 1 (1.5) 0.352
Abruptio placenta 10 (15.4) 3 (4.6) 2 (3.1) 0.016
Fetal distress 14 (21.5) 7 (10.8) 4 (6.2) 0.020
Values are presented as number (%).
EASI, extra-amniotic saline infusion.
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parity, and BMI had not affected the study outcomes, includ-
ing 6-hour Bishop scores and cervical dilatation (Table 4).
Discussion
This study compared the effects of vaginal misoprostol, 
laminaria, and EASI on cervical ripening and labor induction. 
Findings revealed that the time interval from labor induc-
tion to the labor active phase in the EASI group was signifi-
cantly shorter than that in the laminaria and the misoprostol 
groups. Similarly, a previous study reported that this time in-
terval was significantly shorter in the EASI group than in the 
laminaria group [8]. However, contrary to our findings, an-
other study did not find any significant differences between 
the misoprostol and the laminaria groups regarding the time 
intervals between labor induction and the labor active phase, 
attributing this finding to the dose of misoprostol and repeat 
doses [10]. Another study also reported that the time interval 
between labor induction and the labor active phase in the 
misoprostol group was not significantly different from the 
EASI group probably due to the fact that the EASI catheter 
had been using traction [12]. In line with our findings, a 
study reported that the time interval between labor induc-
tion and the labor active phase in the misoprostol group 
was significantly shorter than that in the laminaria group [9]. 
However, contrary to our findings, another study showed 
that this time interval in the misoprostol group did not sig-
nificantly differ from the EASI group [14]. The contradictory 
results between studies was attributable to misoprostol dos-
age differences.
Our findings also indicated that the time interval between 
labor induction and delivery in the EASI group was signifi-
cantly shorter than that in the misoprostol and laminaria 
groups. In contrast, 2 studies showed that the misoprostol 
and EASI groups did not significantly differ from each other 
regarding the induction to delivery time intervals [13,14], and 
several studies have reported significantly shorter induction 
to delivery time intervals in the misoprostol group than in the 
EASI group [7,11,15]. These contradictions may be due to 
the differences in misoprostol dosage among these studies. 
For instance, while misoprostol was administered as a single 
25-µg dose in the present study, it was administered as a 
single 100-µg dose in 1 study [11] and as a 25-µg dose re-
peated every 4 hours in another study [7]. Our findings also 
revealed that the induction to delivery time interval in the 
misoprostol group was significantly shorter than that in the 
laminaria group. A previous study reported the same findings 
[9], while another study reported no significant differences 
between these groups regarding the induction to delivery 
time intervals [10]. 
In the present study, the Bishop score increase in the 
EASI group was significantly greater than that in the other 
2 groups. Contrary to this finding, some studies reported 
that the Bishop score increase in the misoprostol group 
was greater than that in either the EASI or laminaria group 
[9,11,16]. An explanation for this contradiction is the differ-
ence among the studies regarding misoprostol dosages. 
We also found that 6 hours after labor induction, cervi-
cal dilation in the EASI group was significantly greater than 
that in the misoprostol and laminaria groups. In contrast, a 
study reported that cervical dilation 6 hours after induction 
in the laminaria group was 4.4-times greater than that in 
the misoprostol group [10], and another study did not find 
any significant difference between the laminaria and EASI 
groups regarding cervical dilation 6 hours after induction [8]. 
Table 4. Differences in 6-hour Bishop scores and cervical dilatation based on potential confounders
Model
6 hours cervical dilatation 6 hours Bishop score
Beta t Significant Beta t Significant
Constant 1.683 0.094 −0.799 0.425
Group −0.443 −7.718 0.000 −0.331 −5.855 0.000
Age −0.014 −0.228 0.820 0.085 1.479 0.141
Parity 0.066 1.105 0.270 0.045 0.765 0.445
Gestational age 0.029 0.506 0.613 0.148 2.648 0.009
BMI −0.074 −1.300 0.195 −0.050 −0.907 0.365
BMI, body mass index.
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It appears that Foley catheters are more effective in causing 
cervical dilation, while misoprostol is more effective in chang-
ing cervical length and tone [17]. These facts can justify the 
greater effectiveness of mechanical cervical ripening methods 
(such as laminaria or transcervical catheters) in promoting 
cervical dilation. 
The frequencies of cesarean sections in the EASI, misopro-
stol, and laminaria groups were 18.5%, 40%, and 29.2%, 
respectively, and the among group difference was statistically 
significant. Pairwise comparisons revealed that the frequency 
of cesarean sections in the EASI group was significantly less 
than that in the misoprostol group. However, there were no 
significant among group differences regarding the conditions 
which necessitated cesarean sections, including dilation ar-
rest, uterine atony, and chorioamnionitis. In line with these 
findings, a study reported a higher prevalence of cesarean 
sections in the misoprostol group than in the EASI group 
[13]. Two other studies also reported that cesarean section 
rates in the misoprostol group were significantly greater than 
those in the laminaria group, though there were no signifi-
cant between group differences regarding the indications for 
cesarean sections [9,10]. Moreover, in line with our findings, 
a previous study reported no significant differences between 
the laminaria and the trans-cervical groups regarding the 
routes of delivery [8]. The higher rate of cesarean sections in 
the misoprostol group is attributable to the fact that miso-
prostol can cause uterine hypertonicity and, thereby, increase 
the risk of fetal distress and the need for emergency cesar-
ean sections. However, some studies reported lower rates of 
cesarean sections in the misoprostol group than in the EASI 
group [7,16], and some studies found no significant differ-
ence between the misoprostol and the EASI groups regard-
ing the rates of cesarean sections [11,12,14]. The difference 
among the studies regarding the rates of cesarean sections 
in the misoprostol, EASI, and laminaria groups may be due to 
the differences in the therapeutic protocols in different set-
tings. 
In the present study, the rates of placental abruption, fetal 
distress, and meconium staining in the misoprostol group 
were significantly greater than those in the other 2 groups. 
A previous study also reported that the rates of uterine hy-
pertonicity and rupture in the misoprostol group were signifi-
cantly higher than those in the EASI group. A higher uterine 
hypertonicity rate in the misoprostol group in that study 
was similar to our findings; however, there were no cases 
of uterine rupture in our study. This difference between the 
studies may be due to the high dose of misoprostol (100 µg) 
in that study [11]. Contrary to our findings, an earlier study 
reported no significant difference between the misoprostol 
and laminaria groups regarding meconium staining [9]. An-
other study also reported that the rates of maternal and fetal 
consequences, such as uterine hypertonicity, uterine atony, 
and meconium staining, in the misoprostol group did not 
significantly differ from those in the EASI group [7]. However, 
a study found that the misoprostol and EASI groups differed 
significantly from each other regarding uterine hyperstimula-
tion and tachysystole rates and did not differ from each oth-
er regarding meconium staining and chorioamnionitis rates 
[14]. Such differences among the studies are attributable to 
the differences in therapeutic care and patient management 
protocols in different healthcare settings. 
Our findings also showed that the length of hospital stay 
was significantly shorter in the EASI group and significantly 
longer in the misoprostol group. These findings may be due 
to the higher rates of cesarean sections in the misoprostol 
group, which necessitated longer postoperative hospital stay. 
This variable has not been assessed in previous studies.
One of the limitations of this study was its non-blinded 
design because both the physicians and patients were aware 
of the study interventions. The other limitation was that we 
could not control the effects of psychological factors. These 
factors might have affected Bishop scores and labor progres-
sion. The strengths of the study were the large sample size 
(larger than that in previous studies) and the comparison of 
the 3 ripening methods. To the best of our knowledge, no 
previous study has compared the effects of the 3 ripening 
methods.
In conclusion, this study concluded that the EASI ripening 
method is more effective than misoprostol or laminaria in 
shortening the time intervals from labor induction to labor 
active phase and delivery. Moreover, the rates of cesarean 
sections and ripening complications which necessitated ce-
sarean sections were significantly lower in the EASI group. 
Therefore, EASI, as a safe, inexpensive, and easily accessible 
method, is a better option than vaginal misoprostol and 
laminaria for cervical ripening and labor induction. More ex-
tensive studies are recommended to compare the effects of 
combined ripening methods such as combined misoprostol 
and EASI or combined laminaria and oxytocin.
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